Voloridge Investment Management
AMRI

Voloridge Investment Management’s Albany Molecular Research Inc AMRI Stock Holding History

Voloridge Investment Management’s Portfolio AMRI Stock Details AMRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-61,962
Closed -$1.34M – 601
2017
Q2 		$1.34M Buy
+61,962
New +$1.12M 0.03% 300

Other funds holding AMRI

AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Voloridge Investment Management's AMRI Position: Q3 2017 in Review

Voloridge Investment Management sold out of Albany Molecular Research Inc (AMRI) in Q3 2017, closing a stake of 61,962 shares — an estimated $1.34M sold.

Voloridge Investment Management first reported a position in AMRI in Q2 2017 and held it in 1 quarter. The position peaked at $1.34M in Q2 2017. 2 funds tracked by Wall St. Rank hold AMRI as of Q3 2017.

  • Voloridge Investment Management reported no remaining Albany Molecular Research Inc position as of Q3 2017 after selling out during the quarter.
  • Voloridge Investment Management sold 61,962 Albany Molecular Research Inc shares in Q3 2017, an estimated $1.34M.
  • Voloridge Investment Management first reported a position in Albany Molecular Research Inc in Q2 2017 and held it in 1 quarter.
  • Voloridge Investment Management's Albany Molecular Research Inc position peaked at $1.34M in Q2 2017.
  • 2 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q3 2017.

Based on Voloridge Investment Management's 13F filing for Q3 2017, filed 14 Nov 2017.